Browsing by Author Gore, Martin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2006Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group.Millward, Michael; Bedikian, Agop Y.; Conry, Robert; DeConti, Ronald; Gore, Martin; Haluska, Frank G.; Hersey, Peter; Hersh, Evan M.; Kirkwood, John M; Pavlick, Anna C.; Pehamberger, Hubert; Trefzer, Uwe; MedicineBcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(29),2006,pp 4738-4745
2014Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyHarnett, Paul; Bidziński, Mariusz; Blagden, Sarah; Del Prete, Salvatore; Fotopoulou, Christina; Gabra, Hani; Ghamande, Sharad; Gore, Martin; Green, John; Kaye, Stan; Ledermann, Jonathan; Mainwaring, Paul; Spaczyński, Marek; Vergote, Ignace; Vermorken, Jan; Western Clinical School: Medicine (Westmead)Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study, Annals of Oncology, vol.25, 1, 2014,pp 160-165
2014Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyHarnett, Paul; Bidziński, Mariusz; Blagden, Sarah; Del Prete, Salvatore; Fotopoulou, Christina; Gabra, Hani; Ghamande, Sharad; Gore, Martin; Green, John; Kaye, Stan; Ledermann, Jonathan; Mainwaring, Paul; Spaczyński, Marek; Vergote, Ignace; Vermorken, Jan; Western Clinical School: Medicine (Westmead)Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study, Annals of Oncology, vol.25, 1, 2014,pp 160-165